Prosus today announces a €400 million (US$460 million) investment into the European health and insurance tech leader, Alan, valuing it at €5.5 billion (US$6.3 billion).
The investment will consist of both primary and secondary equity.
Prosus is joined in this round by existing investors Teachers’ Venture Growth (TVG) and Index Ventures, and new investor Dara Holdings.
AI has fundamentally changed how people access and experience healthcare. Alan has built an AI-native healthcare platform that brings together insurance, care and prevention in a single, personalised experience.
With a best-in-class product, a platform built for scale and a highly efficient cost of delivery, Alan is uniquely positioned to define the future of health tech.
Alan reached more than €800 million in Annual Recurring Revenue as of Q1 2026, up 53% year-on-year, and profitable in France, its largest market. It serves more than 1.1 million individuals and is scaling with limited headcount growth demonstrating the inherent operating leverage of its AI-led model.
Building a Global Healthtech Platform
Partnering with Alan will unlock mutual benefits. Prosus will support Alan as it scales its consumer offering, help drive Alan’s expansion in large international markets with strong Prosus presence, and accelerate Alan’s AI-led product development, including via access to the Prosus’ Large Commerce Model (LCM). Alan will help Prosus expand its consumer ecosystem proposition into healthcare and bolster Prosus’ life assistant strategy.
“Healthcare presents one of the most significant global opportunities for AI-led transformation,” said Fahd Beg, Head of Investments at Prosus Group.
“Alan has built something unique: an integrated platform where insurance, prevention and care delivery reinforce each other, creating an exceptional healthcare experience for consumers and outstanding platform engagement. We’re excited to partner with Alan to accelerate its international expansion and unlock value through our ecosystem.”
Jean-Charles Samuelian-Werve, Co-founder and CEO of Alan, said: “Health can’t wait, not for symptoms to get worse, not for a six-month appointment, not for the system to catch up. Yet that is exactly how healthcare works today. We believe great health is a universal right, and that prevention should be too. For ten years we have shown that technology can turn healthcare from reactive to proactive, helping people act early instead of reacting late.
“That is what prevention insurance is, and it’s the category we are building. We selected Prosus for their very deep expertise in international expansion and consumer products and to benefit from the incredible ecosystem they are building. We are still at the very beginning of what Alan can become.”
The closing of this financing round is subject to applicable regulatory approvals, including from the relevant French financial authorities.
